Rose, T. L., Ghatalia, P., Deal, A. M., Bjurlin, M., Tan, H., Whang, Y. E., Brower, B. Y., Dunn, M., Kim, W. Y., Milowsky, M. I. (2025). Pathologic response and safety of neoadjuvant pembrolizumab with or without entinostat in muscle-invasive urothelial cancer (MIUC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4603